Symmetric dimethylarginine (SDMA) as endogenous marker of renal function—a meta-analysis

作者: Jan T. Kielstein , Shelley R. Salpeter , Stefanie M. Bode-Boeger , John P. Cooke , Danilo Fliser

DOI: 10.1093/NDT/GFL292

关键词:

摘要: Background. Dosing of most drugs must be adapted in renal insufficiency, making accurate assessment function essential clinical medicine. Furthermore, even modest impairment has been recognized as a cardiovascular risk factor. The purpose this analysis was to identify the role symmetric dimethylarginine (SDMA), structural isomer marker asymmetric dimethylarginine, an endogenous function. Methods. Comprehensive searches Medline and Cochrane Library from 1970 February 2006 were performed studies that evaluated correlation between SDMA search augmented by scanning references identified articles reviews. coefficients (R) recorded each study for values 1/SDMA clearance estimates creatinine levels. summary with 95% confidence intervals (CIs) pooled using random-effects method. Results. In 18 involving 2136 patients systemic concentrations correlated highly inulin [R ¼ 0.85 (CI 0.76–0.91, P < 0.0001)], well various combined 0.77 0.65–0.85, 0.0001)] serum 0.75 0.46–089, 0.0001)]. Conclusions. exhibits some properties reliable Future have clarify whether is indeed suited improve diagnosis eventually optimize care patients.

参考文章(44)
Paloma Lluch, Maria D. Mauricio, José M. Vila, Gloria Segarra, Pascual Medina, Juan A. del Olmo, José M. Rodrigo, Miguel A. Serra, Accumulation of symmetric dimethylarginine in hepatorenal syndrome. Experimental Biology and Medicine. ,vol. 231, pp. 70- 75 ,(2006) , 10.1177/153537020623100108
Hilde M.A. Eid, Harald Arnesen, Elsa M. Hjerkinn, Torstein Lyberg, Ingebjørg Seljeflot, Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine. Metabolism-clinical and Experimental. ,vol. 53, pp. 1574- 1579 ,(2004) , 10.1016/J.METABOL.2004.06.026
Teri Manolio, Novel risk markers and clinical practice. The New England Journal of Medicine. ,vol. 349, pp. 1587- 1589 ,(2003) , 10.1056/NEJMP038136
Joy Ellis, Ulla-Britt Wennerholm, Anders Bengtsson, Håkan Lilja, Anders Pettersson, Bo Sultan, Margareta Wennergren, Henrik Hagberg, Levels of dimethylarginines and cytokines in mild and severe preeclampsia Acta Obstetricia et Gynecologica Scandinavica. ,vol. 80, pp. 602- 608 ,(2001) , 10.1034/J.1600-0412.2001.800703.X
Jesse A. Berlin, Nan M. Laird, Henry S. Sacks, Thomas C. Chalmers, A comparison of statistical methods for combining event rates from clinical trials Statistics in Medicine. ,vol. 8, pp. 141- 151 ,(1989) , 10.1002/SIM.4780080202
Bart Marescau, Guy Nagels, Iise Possemiers, Marc E. De Broe, Ignace Becaus, Jean-Marie Billiouw, Willy Lornoy, Peter P. De Deyn, Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metabolism-clinical and Experimental. ,vol. 46, pp. 1024- 1031 ,(1997) , 10.1016/S0026-0495(97)90273-0
K. E. Kim, G. Onesti, O. Ramirez, A. N. Brest, C. Swartz, Creatinine clearance in renal disease. A reappraisal BMJ. ,vol. 4, pp. 11- 14 ,(1969) , 10.1136/BMJ.4.5674.11
Katarzyna Krzyzanowska, Friedrich Mittermayer, Hans-Peter Kopp, Michael Wolzt, Guntram Schernthaner, Weight Loss Reduces Circulating Asymmetrical Dimethylarginine Concentrations in Morbidly Obese Women The Journal of Clinical Endocrinology and Metabolism. ,vol. 89, pp. 6277- 6281 ,(2004) , 10.1210/JC.2004-0672
L.G. Pedersen, I. Tarnow, L.H. Olsen, T. Teerlink, H.D. Pedersen, Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs Research in Veterinary Science. ,vol. 80, pp. 336- 342 ,(2006) , 10.1016/J.RVSC.2005.07.005
Ellen I. Closs, Fatima Z. Basha, Alice Habermeier, Ulrich Förstermann, Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2B Nitric Oxide. ,vol. 1, pp. 65- 73 ,(1997) , 10.1006/NIOX.1996.0106